We read with great interest the article of Mason et al1 and 2 related editorials2,3 debating the suitability of the time-honored term immune tolerance phase. Their debate was based on current molecular and immunologic findings, and did not reach a consensus. From clinical point of view, we concur with Dr Milich that the term/concept of immune tolerance is still valid.